ATE419861T1 - Peptide mit homing für lymphgefässtumor und ihre verwendung - Google Patents

Peptide mit homing für lymphgefässtumor und ihre verwendung

Info

Publication number
ATE419861T1
ATE419861T1 AT02795599T AT02795599T ATE419861T1 AT E419861 T1 ATE419861 T1 AT E419861T1 AT 02795599 T AT02795599 T AT 02795599T AT 02795599 T AT02795599 T AT 02795599T AT E419861 T1 ATE419861 T1 AT E419861T1
Authority
AT
Austria
Prior art keywords
homing peptides
lymph vessel
vessel tumor
tumor
lymphatic vasculature
Prior art date
Application number
AT02795599T
Other languages
English (en)
Inventor
Pirjo Laakkonen
Kimmo Porkka
Jason Hoffman
Erkki Ruoslahti
Original Assignee
Burnham Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burnham Inst filed Critical Burnham Inst
Application granted granted Critical
Publication of ATE419861T1 publication Critical patent/ATE419861T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02795599T 2001-11-08 2002-11-05 Peptide mit homing für lymphgefässtumor und ihre verwendung ATE419861T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US779201A 2001-11-08 2001-11-08

Publications (1)

Publication Number Publication Date
ATE419861T1 true ATE419861T1 (de) 2009-01-15

Family

ID=21728162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02795599T ATE419861T1 (de) 2001-11-08 2002-11-05 Peptide mit homing für lymphgefässtumor und ihre verwendung

Country Status (7)

Country Link
EP (1) EP1581790B1 (de)
JP (1) JP2005514348A (de)
AT (1) ATE419861T1 (de)
AU (1) AU2002360350A1 (de)
DE (1) DE60230822D1 (de)
ES (1) ES2319624T3 (de)
WO (1) WO2003040693A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501486B2 (en) 2004-09-07 2009-03-10 Burnham Institute For Medical Research Peptides that selectively home to heart vasculature and related conjugates and methods
ATE538806T1 (de) * 2004-09-07 2012-01-15 Burnham Inst Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
CA2638807A1 (en) 2006-02-01 2007-08-09 The Burnham Institute For Medical Research Lymphatic zip codes in tumors and pre-malignant lesions
CA2657649A1 (en) * 2006-07-13 2008-08-21 Burnham Institute For Medical Research Methods and compositions for targeting gc1qr/p32
WO2011027980A2 (en) * 2009-09-02 2011-03-10 Industry-Academic Cooperation Foundation, Chosun University Tumor cell-killing peptides
US8906355B2 (en) * 2009-10-29 2014-12-09 Lucia Irene Gonzalez Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
CA2795289A1 (en) * 2010-04-08 2011-10-13 Sanford-Burnham Medical Research Institute Methods and compositions for enhanced delivery of compounds
KR101551299B1 (ko) * 2013-05-23 2015-09-10 아주대학교산학협력단 뉴로필린에 특이적인 종양 침투성 펩타이드 및 이 펩타이드가 융합된 융합 단백질
WO2016172515A1 (en) 2015-04-23 2016-10-27 Sanford Burnham Prebys Medical Discovery Institute Targeted delivery system and methods of use therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789542A (en) 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
EP0773441B1 (de) * 1995-09-11 2000-08-02 La Jolla Cancer Research Foundation Moleküle, die sich in ausgewählten Organen oder Geweben invivo Einfinden und Verfahren zu ihrer Identifizierung
JP2001501600A (ja) * 1996-09-10 2001-02-06 ザ バーナム インスティテュート 腫瘍ホーミング分子、それに由来する結合体、およびその使用方法
US6287756B1 (en) * 1997-05-05 2001-09-11 Ludwig Institute For Cancer Research Methods for determining presence of cancer in a sample by determining expression of an SSX gene
EP1150701A4 (de) 1999-01-22 2003-03-26 Burnham Inst Zielansteuernde pro-apoptotische konjugate und methoden zu deren verwendung

Also Published As

Publication number Publication date
ES2319624T3 (es) 2009-05-11
EP1581790A2 (de) 2005-10-05
WO2003040693A3 (en) 2006-02-09
JP2005514348A (ja) 2005-05-19
WO2003040693A2 (en) 2003-05-15
EP1581790A4 (de) 2006-07-19
AU2002360350A8 (en) 2006-11-02
EP1581790B1 (de) 2009-01-07
AU2002360350A1 (en) 2003-05-19
DE60230822D1 (de) 2009-02-26

Similar Documents

Publication Publication Date Title
ES2181006T3 (es) Uso de amidas de acidos de piridil alcanos, piridil alquenos y/o piridil alquinos en el tratamiento de tumores o en inmunosupresion.
BG101077A (bg) Пептиди
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
TR200301846T2 (tr) Cripto bloke edici Antikorlar ve bu antikorların kullanımları.
DK1214292T3 (da) Tyrosinderivater
DE69433406T2 (de) Antikörper gegen cd40
CA2265484A1 (en) Tumor homing molecules, conjugates derived therefrom, and methods of using same
CY1117031T1 (el) Μονοκλωνικα αντισωματα εναντι claudin-18 στην αγωγη εναντι καρκινου
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
DE60025832D1 (de) Mehrere zytokin-antikörper komplexen
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
AR033157A1 (es) Uso de proteina alfa de activacion de los fibroblastos ("fapaalfa")bibh1 en el tratamiento del cancer
ATE296312T1 (de) Metalkomplexbildner
ATE332914T1 (de) Mimotope und antimimotope des menschlichen plättchen-glykoproteins ib/ix
DE60230822D1 (de) Peptide mit homing für lymphgefässtumor und ihre verwendung
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE489103T1 (de) Gezielte thrombose durch gewebefaktor polypeptiden
ATE325803T1 (de) Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung
ATE386050T1 (de) Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden
ATE239035T1 (de) Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendungen
ATE293991T1 (de) VERWENDUNG EINES MIT DEM PEPTID ßELAGIGILTVß ASSOZIIERTEN ENTEROBAKTERIEN-PROTEINS OMPA ZUR BEHANDLUNG VON MELANOMEN
NO20020329L (no) Antitumor-antistoffer, proteiner og anvendelse derav
DE60121456D1 (de) Farbstoff-markiertes peptid und dessen verwendung zur diagnostik
MX2023006649A (es) Anticuerpos contra interleucina-22.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties